The chart below shows the treatment the participants took.
279 participants
600 mg total of olaparib a day,
as tablets by mouth.
Olaparib twice a day until their cancer
got worse, the study doctors thought
they should stop study treatment,
or they left the study for another reason
What happened during this study?
The participants were in the study until one of the following happened:
X they chose to stop taking part
X the participant died
X the study team could not contact the participant
The study started in January 2018 and is still ongoing. The study is planned to end
around November 2021. The results presented in this summary are from the data
as of October 2020.
5 | Clinical Study Results